← All trials
NCT04866069
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 25, 2021
- Primary completion
- Oct 31, 2021
- Completion date
- Apr 30, 2022
- First posted
- Apr 29, 2021
- Last posted
- May 6, 2021
- Enrollment
- 50
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The Scientific and Technological Research Council of TurkeyLead sponsor
- The Scientific and Technological Research Council of TurkeySponsor investigator
- The Scientific and Technological Research Council of TurkeyCollaborator
- MonitorCROCollaborator
- VETAL Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.